2018 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2016 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2012 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Networking Rank (Reputation): | > 1000 |
2010 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 2
Sole participant: 1
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2018 | 158.122 | 0 | 158.122 | 1 | ||
2012 | 0 | 3.005.458 | 273.223 | 1 | ||
2010 | 0 | 3.043.599 | 480.720 | 1 |
Total number of partners: 19
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 19
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2018-04-04 | Applying Metabolomics to Unveil follow-up treatment biomarkers and Identify Novel TherapeuticTargets in Glioblastoma | MaGMa | coordinator | 158.122 | 1 |
2012-11-01 | The Sugar Code: from (bio)chemical concept to clinics | GLYCOPHARM | participant | 3.005.458 | 11 |
2010-11-01 | Pulmonary Imaging Network | π-net | participant | 3.043.599 | 10 |